Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company filings document the formal record for a North American branded consumer lawn and garden company. Recent 8-K disclosures furnish operating results and financial condition, revised historical financial information reflecting Hawthorne as a discontinued operation, and the completed sale of The Hawthorne Gardening Company.
The filing record also covers capital structure and governance matters, including a senior secured credit agreement, shareholder approval of an amended and restated Long-Term Incentive Plan, forms of restricted stock unit, performance unit and stock option awards, and definitive proxy disclosures on annual meeting proposals and executive compensation.
Insider transaction summary: Peter E. Shumlin, a director of The Scotts Miracle-Gro Company (SMG), reported the acquisition of 159 dividend-equivalent rights related to DSU/RSU grants on 09/05/2025. The reported price per share equivalent is $63.04 and, after the transaction, Mr. Shumlin beneficially owns 1,023 common shares on a direct basis.
Transaction detail: The filing explains that dividend equivalent rights accrue on DSU/RSU grants and become exercisable proportionately with the underlying units; each right is economically equivalent to one common share. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
Adam Hanft, a director of The Scotts Miracle-Gro Company (SMG), reported a Form 4 disclosing a transaction dated 09/05/2025. The filing shows the acquisition of 104 dividend equivalent rights related to DSU/RSU grants, with an indicated price of $63.04 and resulting beneficial ownership of 662 common shares in a direct form. The filer notes dividend equivalent rights accrue on DSUs/RSUs and become exercisable proportionately, each equivalent equaling one common share. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Hanft on 09/09/2025. The filing does not provide further context on total holdings outside the reported 662 shares.
Mark J. Scheiwer, Executive Vice President, Chief Financial Officer and Chief Accounting Officer of The Scotts Miracle-Gro Company (SMG), reported acquisitions on 09/05/2025. The filing discloses the acquisition of 10.994 units of phantom stock (each unit representing the right to one common share or cash value) and 43 dividend equivalent rights, each tied to common shares. The phantom stock is payable in cash following termination of employment and may be transferred into an alternative investment at any time. The report was signed by an attorney-in-fact on 09/09/2025.
Brian E. Sandoval, a director of The Scotts Miracle-Gro Company (SMG), acquired 156 dividend equivalent rights tied to DSU/RSU awards on 09/05/2025 at an attributable price of $63.04 per share. After the transaction, Mr. Sandoval beneficially owned 965 common shares directly. The filing explains that each dividend equivalent right represents the economic equivalent of one common share and vests proportionately with the related DSUs/RSUs. The Form 4 was signed by an attorney-in-fact on 09/09/2025 and discloses the director-level insider acquisition without additional amendments or other transaction types.
Stephen L. Johnson, a director of The Scotts Miracle-Gro Company (SMG), reported an acquisition on 09/05/2025 of 133 dividend equivalent rights tied to DSU/RSU grants at an economic price of $63.04 each. The filing states each dividend equivalent right is the economic equivalent of one common share. Following the reported transaction, Mr. Johnson beneficially owned 789 common shares directly. The Form 4 was signed on behalf of Mr. Johnson by an attorney-in-fact on 09/09/2025.
David C. Evans, a director of The Scotts Miracle-Gro Company (SMG), acquired dividend equivalent rights equal to 104 common shares on 09/05/2025. These rights are the economic equivalent of one common share each and vest/exercise proportionately with the related DSUs/RSUs. The reported acquisition was recorded at a per-share economic price of $63.04 and after the transaction Mr. Evans directly beneficially owned 662 common shares. The Form 4 was submitted by an attorney-in-fact on behalf of Mr. Evans.
Hagedorn Partnership, L.P., a director and reported 10% owner of The Scotts Miracle-Gro Company (SMG), reported multiple sales of common stock on 09/05/2025. The Form 4 shows three sale transactions totaling 56,633 shares: 41,979 shares at a weighted average price of $62.73, 11,806 shares at $63.69, and 2,848 shares at $64.52. After these sales the reported beneficial holdings remained above 13.2 million shares as held by the Hagedorn Partnership.
The filing states the shares are held indirectly by the Hagedorn Partnership and names the partnership's general partners, who disclaim beneficial ownership except for pecuniary interest. The Form 4 was signed by an attorney-in-fact on behalf of the partnership on 09/08/2025. Detailed per-trade breakdowns are available upon request per the filing.
The Scotts Miracle-Gro Company (SMG) filed a Form 144 reporting a proposed sale of common stock. The notice lists 56,633 shares to be sold through Merrill on 09/05/2025 with an aggregate market value of $3,586,987. The filing shows these shares were originally acquired on 06/16/1995 as a partnership contribution from Community Fund & General Partnership and paid in stock. It also discloses a sale during the past three months: the Hagedorn Partnership sold 70,000 shares on 08/04/2025 for $4,321,000. The filing includes the seller's representation that they possess no undisclosed material adverse information about the issuer.
Mark J. Scheiwer, who serves as EVP, CFO & CAO of The Scotts Miracle-Gro Company (SMG), reported an open-market purchase of common shares on 09/03/2025. The Form 4 shows he acquired 1,790 common shares at $61.32 per share. After the transaction his reported beneficial ownership is 10,129.6898 shares. The filing was signed on behalf of Mr. Scheiwer by an attorney-in-fact, Kathy L. Uttley, on 09/04/2025.
The Scotts Miracle-Gro Company entered into a Second Amendment to its Master Receivables Purchase Agreement with JPMorgan Chase Bank, N.A., extending the receivables purchase program’s Purchase Termination Date from September 1, 2025 to September 1, 2026. This keeps in place a financing facility that allows certain subsidiaries to sell customer receivables to JPMorgan.
Under the amended agreement, the sellers may sell, and JPMorgan may purchase on an uncommitted, weekly basis, up to $750 million of eligible accounts receivable generated from sales to five specified customers. The facility remains largely non-recourse to the sellers and the Company, aside from defined repurchase and indemnification obligations, which are supported by $75 million of standby letters of credit issued under the Company’s senior secured revolving facility. The Company continues to expect to use proceeds from receivables sales for general corporate purposes.